711.6500 -8.45 (-1.17%)
NSE Mar 25, 2025 13:01 PM
Volume: 860.1K
 

711.65
-1.17%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd. is trading above its 30 day SMA of 693.9
More from Syngene International Ltd.
Recommended